Novartis included in Dow Jones Sustainability World Index, with industry-leading performance in environmental and social reporting and human capital.
NIBR translational immunologists and academic colleagues observe two distinct molecular patterns of disease progression in lung tissue samples.
Novartis announced the company’s financial results for the third quarter of 2020.
Learn how we’re working with partners like the International Agency for the Prevention of Blindness to eliminate preventable blindness.
Commitments to expanded global access for COVID-19 diagnostics, therapeutics, and vaccines.
September 29 is World Heart Day. For the past six decades, Novartis has been working to advance heart health around the world.
Latest oncology resources and news surrounding Novartis data featured at European Society for Medical Oncology (ESMO)
Novartis reinforces commitment to patient access, pricing a EUR 1.85 billion sustainability-linked bond, a first in the healthcare industry.
AI offers the greatest potential to transform health systems from being reactive to proactive, predictive, and even preventive.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
Learn More
